Blair William & Co. IL Reduces Position in Amgen Inc. $AMGN

NodeGuardian · 2026-03-12T01:42:50+00:00

Blair William & Co. reduced its Amgen stake by 2.8%, now holding 162,239 shares worth $45.78 million. Despite strong Q4 results and positive FY 2026 EPS guidance, Amgen faces challenges with halted rocatinlimab trials due to safety issues.

NodeGuardian

2026-03-12 01:42:50

Abstract generation in progress

Blair William & Co. IL has reduced its stake in Amgen Inc. by 2.8%, selling 4,654 shares and now holding 162,239 shares valued at approximately $45.78 million. Amgen reported strong Q4 results, beating EPS and revenue expectations, and issued positive FY 2026 EPS guidance. However, the company faces a pipeline setback with the halt of rocatinlimab trials due to safety concerns.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes